相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
Robert A. Nagourney et al.
EJSO (2021)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Francois Quenet et al.
LANCET ONCOLOGY (2021)
Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines
Yu-Lin Lin et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
Shigeki Kusamura et al.
JAMA SURGERY (2021)
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7
Peter Cashin et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
Roxan F. C. P. A. Helderman et al.
CANCERS (2021)
Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging
Marion Larroque et al.
PLEURA AND PERITONEUM (2021)
Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform
Steven D. Forsythe et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
Roxan F. C. P. A. Helderman et al.
CELLS (2020)
Cytoreductive surgery and HIPEC in colorectal cancer-did we get hold of the wrong end of the stick?
Can Yurttas et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2020)
Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
I. Ubink et al.
BRITISH JOURNAL OF SURGERY (2019)
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Charlotte E. L. Klaver et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
Wim Ceelen
EJSO (2019)
Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
Roxan F. C. P. A. Helderman et al.
CANCERS (2019)
Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey
Rafael Morales-Soriano et al.
EJSO (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
Can Yurttas et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols
Markus W. Loeffler et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest
Lea Schaaf et al.
CANCER RESEARCH (2016)
Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed
A. M. Kuijpers et al.
EJSO (2016)
Cytoreductive Surgery and Peritonectomy Procedures
Sanket S. Mehta et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2016)
Looking up: Recent advances in understanding and treating peritoneal carcinomatosis
Laura A. Lambert
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy
A. M. Mehta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
Arlene L. Oei et al.
RADIATION ONCOLOGY (2015)
Intraperitoneal Chemotherapy (IPC) for Peritoneal Carcinomatosis: Review of Animal Models
Felix Gremonprez et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
Mickey K. Kim et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays
Ridha Limame et al.
PLOS ONE (2012)
Learning Curve in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Bijan N. Moradi et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
A tense situation: forcing tumour progression
Darci T. Butcher et al.
NATURE REVIEWS CANCER (2009)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
D Roberts et al.
BRITISH JOURNAL OF CANCER (2005)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
VJ Verwaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
D Elias et al.
ANNALS OF ONCOLOGY (2002)
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
J O'Brien et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)